The APPROACH Study: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Volanesorsen Administered Subcutaneously to Patients with Familial Chylomicronemia Syndrome (FCS)

Journal of clinical lipidology
May 1, 2017
Cited by 43

Abstract


Related Papers

No related papers found

Powered by citation graph analysis